<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT932-4358</title>
	</head>
	<body>
		<main>
			<p>930609 FT  09 JUN 93 / London Stock Exchange: Boots upset A warning over the risks of the heart drug Manoplax pushed down the shares of its maker, Boots. The price of the retail and drugs company fell 5 to 435p in a volume of 2.5m after the Washington-based pharmaceuticals newsletter the Pink Sheet highlighted problems with the drug. Its 100ml dosage must now carry a warning after trial data found that patients taking high dosages were more likely to die than those not taking the drug. One analyst said the revelations added to a question mark over the credibility of Boots and that there must be a long-term doubt over the long-term risk.</p>
		</main>
</body></html>
            